{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,28]],"date-time":"2024-07-28T02:10:13Z","timestamp":1722132613341},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"2","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiol Ther"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s40119-016-0072-4","type":"journal-article","created":{"date-parts":[[2016,9,19]],"date-time":"2016-09-19T06:12:40Z","timestamp":1474265560000},"page":"229-243","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Combined Right Ventricular Outflow Tract Epicardial and Endocardial Late Potential Ablation for Treatment of Brugada Storm: A Case Report and Review of the Literature"],"prefix":"10.1007","volume":"5","author":[{"given":"Sandeep A.","family":"Saha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kousik","family":"Krishnan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Madias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard G.","family":"Trohman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,9,19]]},"reference":[{"issue":"5","key":"72_CR1","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1161\/01.CIR.97.5.457","volume":"97","author":"J Brugada","year":"1998","unstructured":"Brugada J, Brugada R, Brugada P. Right bundle-branch block and ST-segment elevation in leads V1 through V3: a marker for sudden death in patients without demonstrable structural heart disease. Circulation. 1998;97(5):457\u201360.","journal-title":"Circulation"},{"issue":"10","key":"72_CR2","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1093\/europace\/eut272","volume":"15","author":"SG Priori","year":"2013","unstructured":"Priori SG, Wilde AA, Horie M, Cho Y, Behr ER, Berul C, et al. Executive summary: HRS\/EHRA\/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes. Europace. 2013;15(10):1389\u2013406.","journal-title":"Europace"},{"issue":"6","key":"72_CR3","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1161\/CIRCEP.115.003109","volume":"8","author":"B Belhassen","year":"2015","unstructured":"Belhassen B, Rahkovich M, Michowitz Y, Glick A, Viskin S. Management of Brugada syndrome: thirty-three-year experience using electrophysiologically guided therapy with class 1A antiarrhythmic drugs. Circ Arrhythm Electrophysiol. 2015;8(6):1393\u2013402.","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"6","key":"72_CR4","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.hrthm.2007.02.014","volume":"4","author":"T Ohgo","year":"2007","unstructured":"Ohgo T, Okamura H, Noda T, Satomi K, Suyama K, Kurita T, et al. Acute and chronic management in patients with Brugada syndrome associated with electrical storm of ventricular fibrillation. Heart Rhythm. 2007;4(6):695\u2013700.","journal-title":"Heart Rhythm"},{"issue":"8","key":"72_CR5","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1161\/01.CIR.0000088781.99943.95","volume":"108","author":"M Haissaguerre","year":"2003","unstructured":"Haissaguerre M, Extramiana F, Hocini M, Cauchemez B, Jais P, Cabrera JA, et al. Mapping and ablation of ventricular fibrillation associated with long-QT and Brugada syndromes. Circulation. 2003;108(8):925\u20138.","journal-title":"Circulation"},{"issue":"5","key":"72_CR6","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.hrthm.2009.01.007","volume":"6","author":"H Morita","year":"2009","unstructured":"Morita H, Zipes DP, Morita ST, Lopshire JC, Wu J. Epicardial ablation eliminates ventricular arrhythmias in an experimental model of Brugada syndrome. Heart Rhythm. 2009;6(5):665\u201371.","journal-title":"Heart Rhythm"},{"issue":"12","key":"72_CR7","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1161\/CIRCULATIONAHA.110.972612","volume":"123","author":"K Nademanee","year":"2011","unstructured":"Nademanee K, Veerakul G, Chandanamattha P, Chaothawee L, Ariyachaipanich A, Jirasirirojanakorn K, et al. Prevention of ventricular fibrillation episodes in Brugada syndrome by catheter ablation over the anterior right ventricular outflow tract epicardium. Circulation. 2011;123(12):1270\u20139.","journal-title":"Circulation"},{"issue":"6","key":"72_CR8","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1161\/CIRCEP.115.003220","volume":"8","author":"J Brugada","year":"2015","unstructured":"Brugada J, Pappone C, Berruezo A, Vicedomini G, Manguso F, Ciconte G, et al. Brugada syndrome phenotype elimination by epicardial substrate ablation. Circ Arrhythm Electrophysiol. 2015;8(6):1373\u201381.","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"1","key":"72_CR9","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.cpcardiol.2015.06.002","volume":"41","author":"C Antzelevitch","year":"2016","unstructured":"Antzelevitch C, Patocskai B. Brugada syndrome: clinical, genetic, molecular, cellular, and ionic aspects. Curr Probl Cardiol. 2016;41(1):7\u201357.","journal-title":"Curr Probl Cardiol"},{"issue":"19","key":"72_CR10","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.jacc.2008.07.052","volume":"52","author":"B Benito","year":"2008","unstructured":"Benito B, Sarkozy A, Mont L, Henkens S, Berruezo A, Tamborero D, et al. Gender differences in clinical manifestations of Brugada syndrome. J Am Coll Cardiol. 2008;52(19):1567\u201373.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"72_CR11","doi-asserted-by":"crossref","first-page":"3779","DOI":"10.1016\/j.ijcard.2013.06.006","volume":"168","author":"J Ingles","year":"2013","unstructured":"Ingles J, Sarina T, Kasparian N, Semsarian C. Psychological wellbeing and posttraumatic stress associated with implantable cardioverter defibrillator therapy in young adults with genetic heart disease. Int J Cardiol. 2013;168(4):3779\u201384.","journal-title":"Int J Cardiol"},{"issue":"2","key":"72_CR12","first-page":"34","volume":"3","author":"J Tomzik","year":"2015","unstructured":"Tomzik J, Koltermann KC, Zabel M, Willich SN, Reinhold T. Quality of life in patients with an implantable cardioverter defibrillator: a systematic review. Front Cardiovasc Med. 2015;3(2):34.","journal-title":"Front Cardiovasc Med"},{"issue":"5","key":"72_CR13","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1161\/01.CIR.81.5.1482","volume":"81","author":"B Avitall","year":"1990","unstructured":"Avitall B, Port S, Gal R, McKinnie J, Tchou P, Jazayeri M, et al. Automatic implantable cardioverter\/defibrillator discharges and acute myocardial injury. Circulation. 1990;81(5):1482\u20137.","journal-title":"Circulation"},{"issue":"6 Pt 2","key":"72_CR14","first-page":"H2817","volume":"273","author":"M Neunlist","year":"1997","unstructured":"Neunlist M, Tung L. Dose-dependent reduction of cardiac transmembrane potential by high-intensity electrical shocks. Am J Physiol. 1997;273(6 Pt 2):H2817\u201325.","journal-title":"Am J Physiol"},{"issue":"3","key":"72_CR15","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.hrthm.2004.11.019","volume":"2","author":"D Vollmann","year":"2005","unstructured":"Vollmann D, Luthje L, Vonhof S, Unterberg C. Inappropriate therapy and fatal proarrhythmia by an implantable cardioverter\u2013defibrillator. Heart Rhythm. 2005;2(3):307\u20139.","journal-title":"Heart Rhythm"},{"issue":"12","key":"72_CR16","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1016\/S0735-1097(02)01887-9","volume":"39","author":"C Antzelevitch","year":"2002","unstructured":"Antzelevitch C. Late potentials and the Brugada syndrome. J Am Coll Cardiol. 2002;39(12):1996\u20139.","journal-title":"J Am Coll Cardiol"},{"issue":"15","key":"72_CR17","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1161\/01.CIR.0000032002.22105.7A","volume":"106","author":"JM Diego Di","year":"2002","unstructured":"Di Diego JM, Cordeiro JM, Goodrow RJ, Fish JM, Zygmunt AC, Perez GJ, et al. Ionic and cellular basis for the predominance of the Brugada syndrome phenotype in males. Circulation. 2002;106(15):2004\u201311.","journal-title":"Circulation"},{"issue":"8","key":"72_CR18","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/ncpcardio0268","volume":"2","author":"W Shimizu","year":"2005","unstructured":"Shimizu W, Aiba T, Kamakura S. Mechanisms of disease: current understanding and future challenges in Brugada syndrome. Nat Clin Pract Cardiovasc Med. 2005;2(8):408\u201314.","journal-title":"Nat Clin Pract Cardiovasc Med"},{"issue":"9","key":"72_CR19","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1161\/CIRCULATIONAHA.114.013773","volume":"131","author":"P Notarstefano","year":"2015","unstructured":"Notarstefano P, Pieroni M, Guida R, Rio T, Oliva A, Grotti S, et al. Progression of electroanatomic substrate and electric storm recurrence in a patient with Brugada syndrome. Circulation. 2015;131(9):838\u201341.","journal-title":"Circulation"},{"issue":"5","key":"72_CR20","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1161\/CIRCEP.108.790543","volume":"1","author":"PG Postema","year":"2008","unstructured":"Postema PG, van Dessel PF, de Bakker JM, Dekker LR, Linnenbank AC, Hoogendijk MG, et al. Slow and discontinuous conduction conspire in Brugada syndrome: a right ventricular mapping and stimulation study. Circ Arrhythm Electrophysiol. 2008;1(5):379\u201386.","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"4","key":"72_CR21","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/j.1542-474X.2005.00055.x","volume":"10","author":"T Ikeda","year":"2005","unstructured":"Ikeda T, Takami M, Sugi K, Mizusawa Y, Sakurada H, Yoshino H. Noninvasive risk stratification of subjects with a Brugada-type electrocardiogram and no history of cardiac arrest. Ann Noninvasive Electrocardiol. 2005;10(4):396\u2013403.","journal-title":"Ann Noninvasive Electrocardiol"},{"issue":"11","key":"72_CR22","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1111\/j.1540-8167.2011.02054.x","volume":"22","author":"AJ Shah","year":"2011","unstructured":"Shah AJ, Hocini M, Lamaison D, Sacher F, Derval N, Haissaguerre M. Regional substrate ablation abolishes Brugada syndrome. J Cardiovasc Electrophysiol. 2011;22(11):1290\u20131.","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"Suppl 1","key":"72_CR23","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1111\/j.1540-8167.2012.02433.x","volume":"23","author":"B Sunsaneewitayakul","year":"2012","unstructured":"Sunsaneewitayakul B, Yao Y, Thamaree S, Zhang S. Endocardial mapping and catheter ablation for ventricular fibrillation prevention in Brugada syndrome. J Cardiovasc Electrophysiol. 2012;23(Suppl 1):S10\u20136.","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"10","key":"72_CR24","doi-asserted-by":"crossref","first-page":"1249.e9","DOI":"10.1016\/j.cjca.2014.05.019","volume":"30","author":"G Szeplaki","year":"2014","unstructured":"Szeplaki G, Ozcan EE, Osztheimer I, Tahin T, Merkely B, Geller L. Ablation of the epicardial substrate in the right ventricular outflow tract in a patient with Brugada syndrome refusing implantable cardioverter defibrillator therapy. Can J Cardiol. 2014;30(10):1249.e9\u201311.","journal-title":"Can J Cardiol"},{"issue":"5","key":"72_CR25","doi-asserted-by":"crossref","first-page":"305.e1","DOI":"10.1016\/j.repc.2014.01.010","volume":"33","author":"N Cortez-Dias","year":"2014","unstructured":"Cortez-Dias N, Placido R, Marta L, Bernardes A, Sobral S, Carpinteiro L, et al. Epicardial ablation for prevention of ventricular fibrillation in a patient with Brugada syndrome. Rev Port Cardiol. 2014;33(5):305.e1\u20137.","journal-title":"Rev Port Cardiol"},{"issue":"6","key":"72_CR26","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1253\/circj.72.1025","volume":"72","author":"E Nakagawa","year":"2008","unstructured":"Nakagawa E, Takagi M, Tatsumi H, Yoshiyama M. Successful radiofrequency catheter ablation for electrical storm of ventricular fibrillation in a patient with Brugada syndrome. Circ J. 2008;72(6):1025\u20139.","journal-title":"Circ J"},{"issue":"2","key":"72_CR27","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1540-8167.2005.00290.x","volume":"17","author":"A Abud","year":"2006","unstructured":"Abud A, Bagattin D, Goyeneche R, Becker C. Failure of cilostazol in the prevention of ventricular fibrillation in a patient with Brugada syndrome. J Cardiovasc Electrophysiol. 2006;17(2):210\u20132.","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"7","key":"72_CR28","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1046\/j.1540-8167.2002.00698.x","volume":"13","author":"T Tsuchiya","year":"2002","unstructured":"Tsuchiya T, Ashikaga K, Honda T, Arita M. Prevention of ventricular fibrillation by cilostazol, an oral phosphodiesterase inhibitor, in a patient with Brugada syndrome. J Cardiovasc Electrophysiol. 2002;13(7):698\u2013701.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"72_CR29","unstructured":"No authors listed. Potential antiarrhythmic drugs in Brugada syndrome patients. http:\/\/www.brugadadrugs.org\/antiarrhythmic\/ . Accessed 27 Aug 2016."},{"issue":"4","key":"72_CR30","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1213\/ane.0b013e3181aa5cf6","volume":"109","author":"H Gurnaney","year":"2009","unstructured":"Gurnaney H, Brown A, Litman RS. Malignant hyperthermia and muscular dystrophies. Anesth Analg. 2009;109(4):1043\u20138.","journal-title":"Anesth Analg"},{"issue":"4","key":"72_CR31","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1161\/CIRCEP.111.963066","volume":"4","author":"R Bai","year":"2011","unstructured":"Bai R, Di Biase L, Shivkumar K, Mohanty P, Tung R, Santangeli P, et al. Ablation of ventricular arrhythmias in arrhythmogenic right ventricular dysplasia\/cardiomyopathy: arrhythmia-free survival after endo-epicardial substrate based mapping and ablation. Circ Arrhythm Electrophysiol. 2011;4(4):478\u201385.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"72_CR32","doi-asserted-by":"publisher","unstructured":"Corrado D, Zorzi A, Cerrone M, Rigato I, Mongillo M, Bauce B, et al. Relationship between arrhythmogenic right ventricular cardiomyopathy and Brugada syndrome: new insights from molecular biology and clinical implications. Circ Arrhythm Electrophysiol. 2016;9(4). doi: 10.1161\/CIRCEP.115.003631 .","DOI":"10.1161\/CIRCEP.115.003631"},{"issue":"2","key":"72_CR33","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1161\/CIRCEP.110.957290","volume":"4","author":"SR Dukkipati","year":"2011","unstructured":"Dukkipati SR, d\u2019Avila A, Soejima K, Bala R, Inada K, Singh S, et al. Long-term outcomes of combined epicardial and endocardial ablation of monomorphic ventricular tachycardia related to hypertrophic cardiomyopathy. Circ Arrhythm Electrophysiol. 2011;4(2):185\u201394.","journal-title":"Circ Arrhythm Electrophysiol"}],"container-title":["Cardiology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40119-016-0072-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T14:48:14Z","timestamp":1568386094000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40119-016-0072-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,19]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["72"],"URL":"https:\/\/doi.org\/10.1007\/s40119-016-0072-4","relation":{},"ISSN":["2193-8261","2193-6544"],"issn-type":[{"value":"2193-8261","type":"print"},{"value":"2193-6544","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,19]]}}}